Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Faun Pharma AS
AS
Active
Org 883370112
Støttumveien 9, 1543
Vestby
Manufacture of other food products n.e.c.
·
NACE 1089
Est. 2001 · 25 years old
47 employees
Monitor
Share
Norway
/
Companies
/
Manufacture of other food products n.e.c.
/
Faun Pharma AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
229M
172M
115M
57M
0M
2021: 162M
162M
2021
2022: 140M (-14% vs 2021)
140M
-14%
2022
2023: 157M (+12% vs 2022)
157M
+12%
2023
2024: 184M (+17% vs 2023)
184M
+17%
2024
2025: 184M (0% vs 2024)
184M
0%
2025
EBITDA
NOK millions
15M
11M
7M
4M
0M
2021: 12M
12M
2021
2022: 4M (-67% vs 2021)
4M
-67%
2022
2023: 9M (+125% vs 2022)
9M
+125%
2023
2024: 10M (+11% vs 2023)
10M
+11%
2024
2025: 8M (-20% vs 2024)
8M
-20%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
183 641
183 825
157 278
139 952
162 132
Staff expenses
−35 458
−34 585
−27 901
−26 516
−25 847
EBITDA
8 074
10 214
8 507
4 404
12 006
Depreciation & amort.
−2 485
−1 886
−1 642
−1 290
−814
EBIT
5 589
8 328
6 864
3 114
11 192
Net financials
−591
−471
−530
−285
−336
Profit before tax
4 998
7 857
6 334
2 829
10 855
Tax
1 087
1 698
1 361
634
1 426
Net profit
3 911
6 159
4 973
2 196
9 429
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
59 849
61 832
50 227
45 605
39 288
Equity
38 557
34 647
28 488
23 515
21 319
Long-term debt
11 036
12 450
10 833
10 943
3 993
Short-term debt
10 255
14 735
10 907
11 147
13 976
Total debt
21 291
27 185
21 739
22 091
17 969
Financial ratios
5-year trend
EBITDA margin
4,4 %
This company
15,8 %
Market median
This company
Market median
72% below market
2021
2025
Equity ratio
64,4 %
This company
38,2 %
Market median
This company
Market median
69% above market
2021
2025
Return on equity
10,1 %
This company
18,4 %
Market median
This company
Market median
45% below market
2021
2025
Net profit margin
2,1 %
This company
8,1 %
Market median
This company
Market median
74% below market
2021
2025
Asset turnover
3,07×
This company
1,12×
Market median
This company
Market median
174% above market
2021
2025
Debt / equity
0,55×
This company
0,62×
Market median
This company
Market median
11% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Faun Pharma AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
